» Articles » PMID: 36344896

Time to Endoscopic Vacuum Therapy-lessons Learned After > 150 Robotic-assisted Minimally Invasive Esophagectomies (RAMIE) at a German High-volume Center

Abstract

Objective Of The Study: In esophageal surgery, anastomotic leak (AL) remains one of the most severe and critical adverse events after oncological esophagectomy. Endoscopic vacuum therapy (EVT) can be used to treat AL; however, in the current literature, treatment outcomes and reports on how to use this novel technique are scarce. The aim of this study was to evaluate the outcomes of patients with an AL after IL RAMIE and to determine whether using EVT as an treatment option is safe and feasible.

Material And Methods: This study includes all patients who developed an Esophagectomy Complications Consensus Group (ECCG) type II AL after IL RAMIE at our center between April 2017 and December 2021. The analysis focuses on time to EVT, duration of EVT, and follow up treatments for these patients.

Results: A total of 157 patients underwent an IL RAMIE at our hospital. 21 patients of these (13.4%) developed an ECCG type II AL. One patient died of unrelated Covid-19 pneumonia and was excluded from the study cohort. The mean duration of EVT was 12 days (range 4-28 days), with a mean of two sponge changes (range 0-5 changes). AL was diagnosed at a mean of 8 days post-surgery (range 2-16 days). Closure of the AL with EVT was successful in 15 out of 20 patients (75%). Placement of a SEMS (Self-expandlable metallic stent) after EVT was performed in four patients due to persisting AL. Overall success rate of anastomotic sealing independently of the treatment modality was achieved in 19 out of 20 Patients (95%). No severe EVT-related adverse events occurred.

Conclusion: This study shows that EVT can be a safe and effective endoscopic treatment option for ECCG type II AL.

Citing Articles

The Triple-S Advantage of Endoscopic Management in Gastrointestinal Surgery Complications: Safe, Successful, and Savings-Driven.

Mandarino F, Sinagra E, Barchi A, Danese S Life (Basel). 2024; 14(1).

PMID: 38255737 PMC: 10820887. DOI: 10.3390/life14010122.


Reducing the Risks of Esophagectomies: A Retrospective Comparison of Hybrid versus Full-Robotic-Assisted Minimally Invasive Esophagectomy (RAMIE) Approaches.

Hoelzen J, Frankauer B, Szardenings C, Roy D, Pollmann L, Fortmann L J Clin Med. 2023; 12(18).

PMID: 37762765 PMC: 10531670. DOI: 10.3390/jcm12185823.


Endoscopic Vacuum Therapy of Upper Gastrointestinal Anastomotic Leaks: How to Deal with the Challenges (with Video).

Monino L, Moreels T Life (Basel). 2023; 13(6).

PMID: 37374194 PMC: 10302082. DOI: 10.3390/life13061412.


Endoscopic vacuum therapy versus self-expandable metal stent for treatment of anastomotic leaks < 30 mm following oncologic Ivor-Lewis esophagectomy: a matched case-control study.

Mandarino F, Barchi A, Leone L, Fanti L, Azzolini F, Viale E Surg Endosc. 2023; 37(9):7039-7050.

PMID: 37353654 DOI: 10.1007/s00464-023-10213-8.


Don't be afraid of black holes: Vacuum sponge and vacuum stent treatment of leaks in the upper GI tract-a case series and mini-review.

Schafer C Front Surg. 2023; 10:1168541.

PMID: 37206354 PMC: 10191254. DOI: 10.3389/fsurg.2023.1168541.


References
1.
Chon S, Scherdel J, Rieck I, Lorenz F, Dratsch T, Kleinert R . A new hybrid stent using endoscopic vacuum therapy in treating esophageal leaks: a prospective single-center experience of its safety and feasibility with mid-term follow-up. Dis Esophagus. 2021; 35(4). DOI: 10.1093/dote/doab067. View

2.
Rutegard M, Lagergren P, Rouvelas I, Lagergren J . Intrathoracic anastomotic leakage and mortality after esophageal cancer resection: a population-based study. Ann Surg Oncol. 2011; 19(1):99-103. DOI: 10.1245/s10434-011-1926-6. View

3.
Sakamoto T, Fujiogi M, Matsui H, Fushimi K, Yasunaga H . Comparing Perioperative Mortality and Morbidity of Minimally Invasive Esophagectomy Versus Open Esophagectomy for Esophageal Cancer: A Nationwide Retrospective Analysis. Ann Surg. 2019; 274(2):324-330. DOI: 10.1097/SLA.0000000000003500. View

4.
Messager M, Warlaumont M, Renaud F, Marin H, Branche J, Piessen G . Recent improvements in the management of esophageal anastomotic leak after surgery for cancer. Eur J Surg Oncol. 2016; 43(2):258-269. DOI: 10.1016/j.ejso.2016.06.394. View

5.
Kingma B, Hadzijusufovic E, van der Sluis P, Bano E, Lang H, Ruurda J . A structured training pathway to implement robot-assisted minimally invasive esophagectomy: the learning curve results from a high-volume center. Dis Esophagus. 2020; 33(Supplement_2). DOI: 10.1093/dote/doaa047. View